JPH09506883A - 薬 剤 - Google Patents

薬 剤

Info

Publication number
JPH09506883A
JPH09506883A JP7517157A JP51715795A JPH09506883A JP H09506883 A JPH09506883 A JP H09506883A JP 7517157 A JP7517157 A JP 7517157A JP 51715795 A JP51715795 A JP 51715795A JP H09506883 A JPH09506883 A JP H09506883A
Authority
JP
Japan
Prior art keywords
treatment
composition
formula
administered
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7517157A
Other languages
English (en)
Japanese (ja)
Inventor
ブーン，ロナルド・ジェイムズ
グリフィン，デイビッド・ロナルド・ジョン
Original Assignee
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー filed Critical スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー
Publication of JPH09506883A publication Critical patent/JPH09506883A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP7517157A 1993-12-22 1994-12-14 薬 剤 Pending JPH09506883A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9326177.4 1993-12-22
GB939326177A GB9326177D0 (en) 1993-12-22 1993-12-22 Pharmaceuticals
PCT/EP1994/004163 WO1995017190A1 (en) 1993-12-22 1994-12-14 Pharmaceuticals

Publications (1)

Publication Number Publication Date
JPH09506883A true JPH09506883A (ja) 1997-07-08

Family

ID=10747023

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7517157A Pending JPH09506883A (ja) 1993-12-22 1994-12-14 薬 剤

Country Status (8)

Country Link
EP (1) EP0735878A1 (xx)
JP (1) JPH09506883A (xx)
CN (1) CN1084622C (xx)
AU (1) AU697290B2 (xx)
CA (1) CA2179282A1 (xx)
GB (1) GB9326177D0 (xx)
WO (1) WO1995017190A1 (xx)
ZA (1) ZA9410113B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980028023A (ko) * 1996-10-19 1998-07-15 김준웅 Ο-아실-ο-아미노산 9-(4-하이드록시-3-하이드록시메틸부트-1-일구아닌 에스테르 유도체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
EP0216459B1 (en) * 1985-07-27 1990-05-16 Beecham Group Plc 9-substituted guanine monohydrates
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
AU1383495A (en) 1995-07-10
CA2179282A1 (en) 1995-06-29
AU697290B2 (en) 1998-10-01
CN1084622C (zh) 2002-05-15
GB9326177D0 (en) 1994-02-23
EP0735878A1 (en) 1996-10-09
WO1995017190A1 (en) 1995-06-29
ZA9410113B (en) 1995-08-25
CN1142769A (zh) 1997-02-12

Similar Documents

Publication Publication Date Title
JP2008088189A (ja) 潜伏ヘルペスウイルス感染の治療および予防のためのアミノプリン抗ウイルス剤の使用
JP2513519B2 (ja) 薬剤組成物
JPS63145279A (ja) 医薬品生成物
JPH09506883A (ja) 薬 剤
JP2007297412A (ja) ヒト・ヘルペスウイルス−８の治療に対するペンシクロビルの使用
AU696833B2 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
EP0728001B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
RU2181049C2 (ru) Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
JPH09503779A (ja) ヘルペス後の神経痛の治療のためのペンシクロリンの使用
KR100382707B1 (ko) 잠재적허피스바이러스감염의치료및예방을위한아미노퓨린항바이러스제의용도
RU2293562C2 (ru) Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса
JPH10510278A (ja) 潜伏ヘルペスウイルス感染の治療および予防のためのアミノプリン抗ウイルス剤の使用
MXPA97004336A (en) Use of antiviral agents for the treatment and prophylaxis of latent infections of herpesvi
MXPA97006759A (en) Use of penciclovir for the treatment of herpes virus 8 hum

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041102

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20050119

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20050307

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050502

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050712